Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Throat Sprays Market Outlook (2023 to 2033)

The global throat sprays market is expected to reach a valuation of US$ 484.0 million in 2023. Sales of throat sprays are expected to gain traction at a 2.1% CAGR over the forecast period, with the market size reaching US$ 598.3 million by 2033.

One of the primary causes of many respiratory diseases is believed to be rising levels of air pollution and the spread of infections in urban areas. Particulate matter exposure can irritate the throat and induce soreness, which ranges from slight discomfort to severe discomfort.

Throat infections are more common now because of environmental changes, pollution, and air contamination. Manufacturers of throat sprays place a strong emphasis on new product introductions and ongoing innovation using organic ingredients and herbs.

Sales of throat sprays are expected to increase globally, as most throat sprays are over-the-counter (OTC) medicines that do not require a prescription from a doctor. Because customers are conditioned to treat common illnesses like colds, coughs, and sore throats at home rather than seeing a doctor, demand for throat sprays is likely to increase.

The market value for throat sprays was approximately 1.5% of the overall US$ 32.0 billion of the global cold, cough & sore throat remedies market in 2021.

What are the Key Opportunities for Throat Sprays Manufacturers?

High Demand for Affordable Throat Sprays Across Emerging Economies is likely to Fuel Sales

Companies benefit from an increase in global market consolidation activities like mergers and acquisitions, partnerships, and collaboration. Offering well-known cough and cold remedies at affordable pricing is likely to aid in improving sales.

Significant growth prospects for the throat sprays market are anticipated across emerging economies thanks to increased promotional and awareness campaigns and improved healthcare access. These factors cumulatively present lucrative opportunities for growth in the throat sprays sector throughout the forecast period.

Which Factors are Restraining Demand for Throat Sprays?

One of the main barriers preventing the widespread use of specific drugs is medication errors or overdosing. The patient's health negatively be impacted by side effects from overdoses or drug resistance.

For example, sprays sold under different names, such as Hurricane, Topex, and Cetacaine, are frequently used to assist the placement of nasogastric tubes for small procedures. Such anesthetic sprays have the potential to lead to addiction and overdose.

The FDA has issued a warning that certain documented cases of methemoglobinemia have been linked to medication errors because of improper benzocaine spray usage (e.g., longer duration or more frequent sprays than recommended).

Medication errors have a negative impact on a patient's health and hinder the use of the product, which can limit sales in the market. Additionally, the availability of alternatives is likely to limit the use of throat sprays because they are more readily available and more reasonably priced than throat sprays.

Attributes Details
Throat Sprays Market CAGR (2023 to 2033) 2.1%
Throat Sprays Market Size (2023) US$ 484 million
Throat Sprays Market Size (2033) US$ 598.3 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Throat Sprays Industry Historic Outlook Vs 2023 to 2033 Forecast

Sales of throat sprays are forecast to increase at a 2.1% CAGR over the assessment period, in comparison to the CAGR of 2.0% registered between 2018 to 2022, owing to the advent of the infections associated with the COVID-19 pandemic. Market valuation went up from US$ 437.38 million in 2018 to US$ 473.8 million in 2022.

Among the most prevalent illnesses in primary care are upper respiratory tract infections including laryngitis, pharyngitis, nasopharyngitis, and rhinitis. Symptoms include coughing, sore throat, nasal obstruction, and headache.

Even in the absence of treatment, acute sore throats are self-limiting and often go away in 3 to 7 days. However, the discomfort brought on by a sore throat can considerably affect daily activities and quality of life, and it continues to be one of the most frequent causes of primary care consultations.

With peak sales throughout the cold and flu season, sales of throat sprays are expected to gain traction. Ingredients in the formulation could be used to treat symptoms or stop the spread of a viral infection.

Throat sprays are a desirable delivery route for over-the-counter medications, such as sore throat remedies, due to the relatively low developmental barriers. Choosing a reliable and practical medication delivery system is vital to developing brand loyalty in the market.

In the European Union, oral/throat sprays are frequently endorsed as medical devices to prevent common colds. For example, the trypsin/glycerol mouth spray claims that it can shorten/reduce common cold symptoms, stop colds, and stop the host cell infection from the COVID-19 virus.

Topical delivery methods provide various benefits over systemic drug administration, including enhanced product bioavailability, decreased adverse and off-target effects, and greater patient convenience, which promotes compliance. For effective delivery of medications for pain relief, throat sprays are a preferred mode of administration to provide symptomatic relief to patients with common cold and associated infections of the throat.

Comparative View of the Market

Throat Sprays Market:

Attributes Throat Sprays Market
CAGR (2023 to 2033) 2.1%
Market Value (2023) US$ 598.3 million
Growth Factor Focus on active delivery systems
Opportunity Affordability in different countries
Trends Promotional and awareness campaigns

Strep Throat Treatment Market:

Attributes Strep Throat Treatment Market
CAGR (2023 to 2033) 4.4%
Market Value (2023) US$ 3,200 million
Growth Factor Surging investment from foreign investors
Opportunity Growing incidence of bacterial infections
Trends Public awareness and campaigns automation

Cold, Cough and Sore Throat Remedies Market:

Attributes Cold, Cough and Sore Throat Remedies Market
CAGR (2023 to 2033) 0.6%
Market Value (2023) US$ 37,930 million
Growth Factor Rising prevalence of infectious disease
Opportunity Rising government initiatives
Trends Surging sales of oral drugs
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Country Market Share (2023)
United States 34.7%
Germany 6.1%
Japan 5.0%
Australia 1.5%

What is Driving the United States Throat Sprays Market?

Increasing Demand for Sore Throat Sprays is likely to Boost Sales

The United States dominated the North America throat sprays industry in 2022, holding 90.1% of the market share. As per FMI, the trend is expected to continue over the forecast period owing to numerous awareness campaigns aimed at reducing infectious diseases as well as the existence of various key throat sprays and lozenge manufacturers in the country.

What is the Germany Throat Sprays Sector Outlook?

Growing Sales of Antiseptic Throat Sprays in Germany is likely to Fuel Growth

Demand in the Germany market is set to increase at a 2.9% CAGR over the assessment period. Rising prevalence of throat infections, owing to environmental factors such as cold weather conditions is spurring demand for throat sprays. With a high prevalence of throat infections in the pediatric population, manufacturers are launching throat sprays for kids for pain relief.

What Makes the China Throat Sprays Market Considered Lucrative?

Consumers in China are Preferring Throat Spray for Cough

China held approximately 53.2% of the East Asia throat sprays market share in 2021, and sales are projected to increase at a 1.9% CAGR over the assessment period. Manufacturers in China are developing herbal nasal and throat spray from longan extract for infections such as COVID-19, which has increased the adoption of herbal formulations for throat sprays.

Category-wise Insights

Which Spray Type is Driving the Throat Sprays Business?

Demand for Anaesthetic Throat Sprays is likely to Gain Traction

Based on spray type, sales of anesthetic throat sprays is likely to increase at a 2.4% CAGR by 2033. Initially, it held 29.5% of the total market share in 2022. The spray contains a local anesthetic with rapid onset of action. It delivers the spray directly to the area of pain for targeted pain relief, quickly relieving discomfort associated with a sore throat.

Which Closures of Throat Sprays is Largely in Focus?

Sales of Pumps and Dispensers is likely to Remain High

Pumps and dispensers hold a revenue share of around 66.3% in 2022 and are expected to display gradual growth over the forecast period. Growing concerns about the environmental impact of aerosols is expected to fuel sales in this segment. Thus, sustainable products are increasingly preferred over traditional sprays.

Which Distribution Channel Benefits the Most With the Sales of Throat Sprays?

Demand for Throat Sprays in Hospital Pharmacies is likely to Increase

Hospital pharmacies accounted for the leading share 33.4% in 2022, and the trend is expected to continue over the forecast period. The prevalence of chronic and infectious disorders is on the rise, which continue pushing sales in this segment over the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

Battle of the Sprays: Competitors Vie for Dominance in the Throat Sprays Industry

Technology advancements, strategic partnerships, R&D spending, and research all contribute significantly to the market expansion for throat sprays. Instances of key developmental strategies by the industry players in the throat sprays market are:

  • The issue of a BupiZenge connected to a European patent was announced by Moberg Pharma and its subsidiary in January 2021. A bupivacaine-containing prolonged-release lozenge for treating or reducing oral cavity discomfort is part of the new invention.
  • In July 2020, Vitabeauti.com, a top fitness and health e-commerce site in the USA, started selling the fully licenced Cool Day energizing lozenges online.
  • In November 2021, Reckitt announced the launch of their new product known as Mucinex InstaSoothe. This new product line includes lozenges and sprays designed to numb, soothe, and relieve sore throat pain.
  • In July 2018, Cipla acquired South African over-the-counter medicine (OTC) manufacturer and distributor Mirren, for INR 2.28 billion. The acquisition brings cold, flu, and pain relief brands to Cipla.

Key Players

  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC.
  • Purdue Pharma
  • Procter & Gamble
  • Cipla Limited
  • iNova Pharmaceuticals (Difflam)
  • Marinomed Biotech AG
  • Biocidin Botanicals
  • URSATEC GmbH
  • Martin & Pleasance
  • Mega We Care
  • PFL Healthcare (Snoreeze)
  • Zenta Healthcare Private Limited
  • Puressentiel Laboratory
  • Melcare Biomedical
  • Laboratoire Les 3 CHÊNES

Key Segments

By Spray Type:

  • Anaesthetics
  • Anti-inflammatory
  • Pain Relief
  • Anti-bacterial
  • Natural Extract

By Closures:

  • Aerosol Sprays
  • Pump and Dispensers

By Capacity:

  • 5 ml
  • 10-15 ml
  • 20-30 ml
  • >30 ml

By Distribution Channel:

  • Retail Store Chains
  • Drug Stores
  • Hospital Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA

Frequently Asked Questions

How big is the Throat Sprays Market by 2033?

The projected revenue of the market by 2033 is US$ 598.3 million.

What is the Throat Sprays Market CAGR for 2033?

The market CAGR for 2033 is projected to be 2.1%.

Who are the Three Key Players in the Throat Sprays Market?

Vicks, Strepsils, and Chloraseptic. are the key market players.

What is the Current Throat Sprays Market Valuation?

The market is estimated to secure a valuation of US$ 484 million in 2023.

Why is the North American Throat Sprays Market Growing Remarkably Fast?

North America is growing fast due to the increasing prevalence of respiratory diseases.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Spray Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Spray Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Spray Type, 2023 to 2033

        5.3.1. Anaesthetics Throat Sprays

        5.3.2. Anti-inflammatory Throat Sprays

        5.3.3. Pain Relief Throat Sprays

        5.3.4. Anti-bacterial Throat Sprays

        5.3.5. Natural Extract Throat Sprays

    5.4. Y-o-Y Growth Trend Analysis By Spray Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Spray Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Closures

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Closures, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Closures, 2023 to 2033

        6.3.1. Aerosol Sprays

        6.3.2. Pump and Dispensers

    6.4. Y-o-Y Growth Trend Analysis By Closures, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Closures, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capacity, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capacity, 2023 to 2033

        7.3.1. 5 ml

        7.3.2. 10-15 ml

        7.3.3. 20-30 ml

        7.3.4. >30 ml

    7.4. Y-o-Y Growth Trend Analysis By Capacity, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Capacity, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033

        8.3.1. Retail Store Chains

        8.3.2. Drug Stores

        8.3.3. Hospital Pharmacies

        8.3.4. Online Pharmacies

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Spray Type

        10.2.3. By Closures

        10.2.4. By Capacity

        10.2.5. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Spray Type

        10.3.3. By Closures

        10.3.4. By Capacity

        10.3.5. By Distribution Channel

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Spray Type

        11.2.3. By Closures

        11.2.4. By Capacity

        11.2.5. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Spray Type

        11.3.3. By Closures

        11.3.4. By Capacity

        11.3.5. By Distribution Channel

    11.4. Key Takeaways

12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Spray Type

        12.2.3. By Closures

        12.2.4. By Capacity

        12.2.5. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Spray Type

        12.3.3. By Closures

        12.3.4. By Capacity

        12.3.5. By Distribution Channel

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Spray Type

        13.2.3. By Closures

        13.2.4. By Capacity

        13.2.5. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Spray Type

        13.3.3. By Closures

        13.3.4. By Capacity

        13.3.5. By Distribution Channel

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Spray Type

        14.2.3. By Closures

        14.2.4. By Capacity

        14.2.5. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Spray Type

        14.3.3. By Closures

        14.3.4. By Capacity

        14.3.5. By Distribution Channel

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Spray Type

        15.2.3. By Closures

        15.2.4. By Capacity

        15.2.5. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Spray Type

        15.3.3. By Closures

        15.3.4. By Capacity

        15.3.5. By Distribution Channel

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Spray Type

        16.2.3. By Closures

        16.2.4. By Capacity

        16.2.5. By Distribution Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Spray Type

        16.3.3. By Closures

        16.3.4. By Capacity

        16.3.5. By Distribution Channel

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Spray Type

            17.1.2.2. By Closures

            17.1.2.3. By Capacity

            17.1.2.4. By Distribution Channel

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Spray Type

            17.2.2.2. By Closures

            17.2.2.3. By Capacity

            17.2.2.4. By Distribution Channel

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Spray Type

            17.3.2.2. By Closures

            17.3.2.3. By Capacity

            17.3.2.4. By Distribution Channel

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Spray Type

            17.4.2.2. By Closures

            17.4.2.3. By Capacity

            17.4.2.4. By Distribution Channel

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Spray Type

            17.5.2.2. By Closures

            17.5.2.3. By Capacity

            17.5.2.4. By Distribution Channel

    17.6. UK

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Spray Type

            17.6.2.2. By Closures

            17.6.2.3. By Capacity

            17.6.2.4. By Distribution Channel

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Spray Type

            17.7.2.2. By Closures

            17.7.2.3. By Capacity

            17.7.2.4. By Distribution Channel

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Spray Type

            17.8.2.2. By Closures

            17.8.2.3. By Capacity

            17.8.2.4. By Distribution Channel

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Spray Type

            17.9.2.2. By Closures

            17.9.2.3. By Capacity

            17.9.2.4. By Distribution Channel

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Spray Type

            17.10.2.2. By Closures

            17.10.2.3. By Capacity

            17.10.2.4. By Distribution Channel

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Spray Type

            17.11.2.2. By Closures

            17.11.2.3. By Capacity

            17.11.2.4. By Distribution Channel

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Spray Type

            17.12.2.2. By Closures

            17.12.2.3. By Capacity

            17.12.2.4. By Distribution Channel

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Spray Type

            17.13.2.2. By Closures

            17.13.2.3. By Capacity

            17.13.2.4. By Distribution Channel

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Spray Type

            17.14.2.2. By Closures

            17.14.2.3. By Capacity

            17.14.2.4. By Distribution Channel

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Spray Type

            17.15.2.2. By Closures

            17.15.2.3. By Capacity

            17.15.2.4. By Distribution Channel

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Spray Type

            17.16.2.2. By Closures

            17.16.2.3. By Capacity

            17.16.2.4. By Distribution Channel

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Spray Type

            17.17.2.2. By Closures

            17.17.2.3. By Capacity

            17.17.2.4. By Distribution Channel

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Spray Type

            17.18.2.2. By Closures

            17.18.2.3. By Capacity

            17.18.2.4. By Distribution Channel

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Spray Type

            17.19.2.2. By Closures

            17.19.2.3. By Capacity

            17.19.2.4. By Distribution Channel

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Spray Type

            17.20.2.2. By Closures

            17.20.2.3. By Capacity

            17.20.2.4. By Distribution Channel

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Spray Type

            17.21.2.2. By Closures

            17.21.2.3. By Capacity

            17.21.2.4. By Distribution Channel

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2022

            17.22.2.1. By Spray Type

            17.22.2.2. By Closures

            17.22.2.3. By Capacity

            17.22.2.4. By Distribution Channel

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2022

            17.23.2.1. By Spray Type

            17.23.2.2. By Closures

            17.23.2.3. By Capacity

            17.23.2.4. By Distribution Channel

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Spray Type

        18.3.3. By Closures

        18.3.4. By Capacity

        18.3.5. By Distribution Channel

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Prestige Consumer Healthcare Inc.

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

                19.1.1.5.2. Product Strategy

                19.1.1.5.3. Channel Strategy

        19.1.2. Reckitt Benckiser Group PLC.

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

                19.1.2.5.2. Product Strategy

                19.1.2.5.3. Channel Strategy

        19.1.3. Purdue Pharma

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

                19.1.3.5.2. Product Strategy

                19.1.3.5.3. Channel Strategy

        19.1.4. Procter & Gamble

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

                19.1.4.5.2. Product Strategy

                19.1.4.5.3. Channel Strategy

        19.1.5. Cipla Limited

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

                19.1.5.5.2. Product Strategy

                19.1.5.5.3. Channel Strategy

        19.1.6. iNova Pharmaceuticals (Difflam)

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

                19.1.6.5.2. Product Strategy

                19.1.6.5.3. Channel Strategy

        19.1.7. Marinomed Biotech AG

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

                19.1.7.5.2. Product Strategy

                19.1.7.5.3. Channel Strategy

        19.1.8. Biocidin Botanicals

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

                19.1.8.5.2. Product Strategy

                19.1.8.5.3. Channel Strategy

        19.1.9. URSATEC GmbH

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

                19.1.9.5.2. Product Strategy

                19.1.9.5.3. Channel Strategy

        19.1.10. Martin & Pleasance

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

                19.1.10.5.2. Product Strategy

                19.1.10.5.3. Channel Strategy

        19.1.11. Mega We Care

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

                19.1.11.5.2. Product Strategy

                19.1.11.5.3. Channel Strategy

        19.1.12. PFL Healthcare (Snoreeze)

            19.1.12.1. Overview

            19.1.12.2. Product Portfolio

            19.1.12.3. Profitability by Market Segments

            19.1.12.4. Sales Footprint

            19.1.12.5. Strategy Overview

                19.1.12.5.1. Marketing Strategy

                19.1.12.5.2. Product Strategy

                19.1.12.5.3. Channel Strategy

        19.1.13. Zenta Healthcare Private Limited

            19.1.13.1. Overview

            19.1.13.2. Product Portfolio

            19.1.13.3. Profitability by Market Segments

            19.1.13.4. Sales Footprint

            19.1.13.5. Strategy Overview

                19.1.13.5.1. Marketing Strategy

                19.1.13.5.2. Product Strategy

                19.1.13.5.3. Channel Strategy

        19.1.14. Puressentiel Laboratory

            19.1.14.1. Overview

            19.1.14.2. Product Portfolio

            19.1.14.3. Profitability by Market Segments

            19.1.14.4. Sales Footprint

            19.1.14.5. Strategy Overview

                19.1.14.5.1. Marketing Strategy

                19.1.14.5.2. Product Strategy

                19.1.14.5.3. Channel Strategy

        19.1.15. Melcare Biomedical

            19.1.15.1. Overview

            19.1.15.2. Product Portfolio

            19.1.15.3. Profitability by Market Segments

            19.1.15.4. Sales Footprint

            19.1.15.5. Strategy Overview

                19.1.15.5.1. Marketing Strategy

                19.1.15.5.2. Product Strategy

                19.1.15.5.3. Channel Strategy

        19.1.16. Laboratoire Les 3 CHÊNES

            19.1.16.1. Overview

            19.1.16.2. Product Portfolio

            19.1.16.3. Profitability by Market Segments

            19.1.16.4. Sales Footprint

            19.1.16.5. Strategy Overview

                19.1.16.5.1. Marketing Strategy

                19.1.16.5.2. Product Strategy

                19.1.16.5.3. Channel Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Respiratory Inhaler Devices Market

Published : April 2023

Healthcare

Strep Throat Treatment Market

Published : March 2023

Explore Healthcare Insights

View Reports